Soon after turning one and taking his first steps, Ryan began facing a lot of challenges. He had to have his spleen removed ...

Papitto Opportunity Connection is hoping to help people struggling with a disease that it claims is "woefully understudied ...

Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain ...

Patricia McGill is among the oldest people in the U.S. with sickle cell disease, and she attributes her longevity to optimism ...

U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where ...

The healthcare company said clinical data indicates the overall benefit of Oxbryta no longer outweighs the risk in the ...

Pfizer had big hopes for a sickle-cell disease drug, as did those suffering from the disease. Things didn't turn out as ...

Pfizer Inc. said late Wednesday it was withdrawing a sickle-cell drug from markets worldwide and discontinuing clinical ...

Pfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because of safety concerns. Pfizer ( PFE) ...

This article is authored by Chetan Makam, senior vice president and general manager, Global Blood Solutions, Terumo Blood and ...

The company said it was withdrawing Oxbryta, a daily pill for patients with the disease, a serious, lifelong condition.